Decreasing sample size in primary prevention studies: A potential role for coronary artery calcium score

Abstract

Get full access to this article

View all access options for this article.

References

Ostovaneh

Poustchi

Hemming

. Polypill for the prevention of cardiovascular disease (PolyIran): Study design and rationale for a pragmatic cluster randomized controlled trial. Eur J Prev Cardiol. Epub ahead of print2014.

Bittencourt

Blaha

Blankstein

. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2014; 63: 434–443.